Sort
130,381 grants matching “hiv”
A randomised study of interferon-free treatment for recently acquired hepatitis C in people who inject drugs and people with HIV coinfection (the REACT Study)
$964,605Gail Matthews · University Of New South Wales · R01 · FY2018 · DA
University of Miami Pediatric Perinatal HIV/AIDS Clinical Trails Unit
$964,543Gwendolyn B. Scott · University Of Miami School Of Medicine · UM1 · FY2013 · AI
Engineering Bacteriophage T4 as a Targeted Gene Therapy Drug for in vivo HIV Cure
$964,530Venigalla B. Rao · Catholic University Of America · DP1 · FY2024 · DA
Engineering Bacteriophage T4 as a Targeted Gene Therapy Drug for in vivo HIV Cure
$964,530Venigalla B. Rao · Catholic University Of America · DP1 · FY2025 · DA
PANDAA for universal, pan-lineage molecular detection of filoviruses to enable rapid epidemic response.
$964,499Iain James Macleod · Aldatu Biosciences, Inc. · R44 · FY2022 · AI
Preclinical and clinical studies of an HBV rapid test for FDA Pre-market approval
$964,487Helen H Lee · Diagnostics For The Real World, Ltd · R44 · FY2007 · HL
Aligning facility leadership and climate to advance mental health services integration in Malawi
$964,486Brian W Pence · Univ Of North Carolina Chapel Hill · R01 · FY2025 · MH
X-ray Crystallographic Fragment Screening Core
$964,449Edward V Arnold · Scripps Research Institute, The · U54 · FY2017 · GM
Diverting homeless youth/chronic homelessness/risk/HIV
$964,072Norweeta Germaine Milburn · University Of California Los Angeles · R01 · FY2006 · MH
Strategies to optimize ART services for maternal&child health: the MCH-ART study
$963,966Elaine Janine Abrams · Columbia University Health Sciences · R01 · FY2013 · HD
Point-of-care C-reactive protein-based tuberculosis screening in people living with HIV: a randomized trial
$963,941Christina Yoon · University Of California, San Francisco · R61 · FY2019 · HL
Durable HIV Vaccine Targeting Mucosal Epithelium
$963,873Marie-Claire Elisabeth Gauduin · Texas Biomedical Research Institute · R01 · FY2025 · AI
COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$963,863Jane Baker · Philadelphia Departmentof Public Health · U62 · FY2016 · PS
Single-Cell Transcriptomics of Non-Activated Latently Infected T cells Isolated from HIV+ Drug Users
$963,778Melanie Maria Ott · J. David Gladstone Institutes · R33 · FY2022 · DA
Individual, Network and Spatial Drivers of HIV and HCV among PWID in India
$963,776Sunil Suhas Solomon · Johns Hopkins University · R01 · FY2017 · DA
Ontogeny &Maintenance of Virus Specific T Cells
$963,735Univ Of Massachusetts Med Sch Worcester · P01 · FY2001 · AI
Scaling up HPTN 074: a Cluster Randomized Implementation Trial of an Evidence-based Intervention for Antiretroviral Therapy for PWID in Vietnam
$963,689Vivian F. Go · Univ Of North Carolina Chapel Hill · R01 · FY2019 · DA
Role of Memory T Cell Dynamics in SIV Infection
$963,517Louis J. Picker · Oregon Health & Science University · R37 · FY2015 · AI
Implementing depression and adherence treatment in S. Africa HIV care
$963,515Steven A Safren · University Of Miami Coral Gables · R01 · FY2024 · MH
Xenogeneic Stem Cell and Thymic Replacement in AIDS
$963,510Massachusetts General Hospital · P01 · FY2004 · AI
A nurse-led intervention to extend the HIV treatment cascade for cardiovascular disease prevention (EXTRA-CVD)
$963,461Chris Todd Longenecker · Case Western Reserve University · U01 · FY2019 · HL
India International Center for Excellence in Research
$963,448Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
The Impact of Early Medical Treatment in Transgender Youth
$963,441Johanna L Olson-Kennedy · Children'S Hospital Of Los Angeles · R01 · FY2023 · HD
Gene-Environment Interplay in the Development of Drug Abuse, HIV Sexual Risk Beha
$963,389Karl Gordon Hill · University Of Washington · R01 · FY2011 · DA
Basic and Comparative Studies of CCR5 Inhibition to Prevent HIV Transmission
$963,378Michael Marcel Lederman · Case Western Reserve University · U19 · FY2010 · AI